| Document Date: 2005-10-18 14:23:46
Open Document File Size: 86,35 KBShare Result on Facebook
City West Warwick / Montréal / Santa Barbara / New York / South Natick / Ithaca / Burnaby / / Company AMP / McGraw-Hill / Sigma-Aldrich Canada Ltd. / Novartis Pharma Canada / Wilson / Lifescan Canada Ltd. / Astro-Med Inc. / Transonic Systems Inc. / / Country Canada / / / IndustryTerm stock solution / physiological solution / food / glycation end products / normal solution / mM stock solutions / / MedicalCondition polyuria / loss of consciousness / vascular diseases / STZ-induced diabetes / streptozotocin-induced diabetes mellitus / Streptozotocin-induced diabetes / STZinduced diabetes / congestive heart failure / cardiovascular disorders / hypertension / disease / atherosclerosis / Shortterm diabetes / diabetic complications / STZ-induced diabetes mellitus / hyperglycemia / Stroke / diabetes / Cardiovascular disease / streptozotocin-induced NIDDM / diabetes mellitus / diseases / usual diabetes mellitus complications / uncontrolled diabetes mellitus / / MedicalTreatment cannula / / NaturalFeature KATP channel / / Organization Canadian Diabetes Association / Canadian Council on Animal Care / Harvard / Succursale Centre / Nuclear Regulatory Commission / / Person Hashimoto / Jean-François Bouchard / Blair / Éric C. Dumont / Turk / / Position model 11 / model 79 / model T106 / Author / vp November / / Product nifedipine / dimethyl sulfoxide / sodium nitroprusside / / ProvinceOrState British Columbia / New York / Rhode Island / California / Massachusetts / Ontario / / Technology flow probe / /
SocialTag |
Color profile: Disabled Composite Default screen 980 Modification of vasodilator response in